Abbott's (ABT) Q3 Earnings Top Estimates, 2022 EPS View Up (Revised)

11:31am, Thursday, 20'th Oct 2022 Zacks Investment Research
Abbott's (ABT) Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
Abbott's (ABT) Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of E
U.S. stocks ended a choppy session lower on Wednesday as another batch of mostly positive corporate earnings was offset by an ongoing rise in Treasury yields.

Why Abbott Laboratories Stock Is Slumping Today

06:10pm, Wednesday, 19'th Oct 2022 The Motley Fool
A potential drop-off in COVID-19 testing sales is weighing on the healthcare giant's shares today.
Abbott (ABT) delivered earnings and revenue surprises of 26.37% and 8.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Abbott Laboratories CEO Robert Ford says the company replaced leadership at its troubled Michigan facility and is building a new infant formula plant.

3 Stocks Set to Soar From 52-Week Lows

04:39pm, Wednesday, 19'th Oct 2022
The stock market remains near 52-week lows, and it might be the time to start looking for stocks to buy at a discount. Following September's inflation figures, things don't appear to change soon.
Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share. Scopus BioPharma Inc. (NASDAQ:

Abbott's (ABT) Q2 Earnings Top Estimates, 2022 EPS View Up

04:21pm, Wednesday, 19'th Oct 2022 Zacks Investment Research
Abbott's (ABT) Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.

Abbott Laboratories (ABT) Q3 2022 Earnings Call Transcript

04:00pm, Wednesday, 19'th Oct 2022 The Motley Fool
ABT earnings call for the period ending September 30, 2022.
RBC Capital Analyst Shagun Singh Chadha joins Yahoo Finance Live anchor AKiko Fujita to discuss Abbott earnings and growth in its business segments including COVID testing, baby formula, and nutrition
The company, which had halted production at the Sturgis, Mich., plant earlier in the year, also said it will spend $500 million to build a new formula plant.

U.S. Housing Starts Declined in September

02:57pm, Wednesday, 19'th Oct 2022 Zacks Investment Research
U.S. Housing Starts Declined in September
Is the billion-dollar COVID-19 testing sales boom over?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE